Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103:981–91.
Liu J, Ghaziani TT, Wolf JL. Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management. Am J Gastroenterol. 2017;112:838–46.
Article CAS PubMed Google Scholar
Jamjute P, Ahmad A, Ghosh T, Banfield P. Liver function test and pregnancy. J Matern Fetal Neonatal Med. 2009;22:274–83.
Article CAS PubMed Google Scholar
Liu H, Zhang L, Ainiwan D, Chi P, Cheng H, Alifu X, et al. Associations of maternal liver biomarkers in the first trimester with the risk of hypertensive disorders of pregnancy. Hypertens Res. 2024. https://doi.org/10.1038/s41440-024-01722-7.
Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613–22.
Article CAS PubMed Google Scholar
Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33:8–15.
Redman CW, Tannetta DS, Dragovic RA, Gardiner C, Southcombe JH, Collett GP, et al. Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta. 2012;33:S48–54.
Naruse K, Sado T, Noguchi T, Tsunemi T, Yoshida S, Akasaka J, et al. Peripheral RAGE (receptor for advanced glycation endproducts)-ligands in normal pregnancy and preeclampsia: novel markers of inflammatory response. J Reprod Immunol. 2012;93:69–74.
Article CAS PubMed Google Scholar
Akasaka J, Naruse K, Sado T, Uchiyama T, Makino M, Yamauchi A, et al. Involvement of receptor for advanced glycation endproducts in hypertensive disorders of pregnancy. Int J Mol Sci. 2019;20:5462.
Article CAS PubMed PubMed Central Google Scholar
Kumasawa K, Iriyama T, Nagamatsu T, Osuga Y, Fujii T. Pravastatin for preeclampsia: from animal to human. J Obstet Gynaecol Res. 2020;46:1255–62.
留言 (0)